• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[이데일리] 김건수 큐로셀 대표 “림프종 이어 내달 CAR-T 백혈병 임상 본격화”

2022/10/27

김건수 큐로셀 대표 “림프종 이어 내달 CAR-T 백혈병 임상 본격화” (edaily.co.kr)

이데일리 김진호 기자

Prev큐로셀, CAR-T 치료제 상업용 GMP 공장건설 관련 대전시 투자보조금 지원사업 선정
Next큐로셀, 급성림프모구성 백혈병(성인 B-ALL) CAR-T 치료제 국내 임상 개시
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.